paclitaxel has been researched along with Carcinoma, Basal Cell, Pigmented in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Daniel, FJ; Davis, ID; Jefford, M; Kiffer, JD; Somers, G | 1 |
| Barceló, R; Gil-Negrete, A; López-Vivanco, G; Muñoz, A; Rubio, I; Viteri, A | 1 |
2 other study(ies) available for paclitaxel and Carcinoma, Basal Cell, Pigmented
| Article | Year |
|---|---|
Metastatic basal cell carcinoma: rapid symptomatic response to cisplatin and paclitaxel.
Topics: Antineoplastic Agents; Carcinoma, Basal Cell; Cisplatin; Humans; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Remission Induction; Skin Neoplasms; Time Factors | 2004 |
Paclitaxel for progressive basal cell carcinoma.
Topics: Aged; Antineoplastic Agents, Phytogenic; Carcinoma, Basal Cell; Eyelid Neoplasms; Humans; Male; Middle Aged; Paclitaxel; Skin Neoplasms | 2006 |